A neurologist's personal battle against Alzheimer's disease
As we all know by now, finding an effective treatment for Alzheimer’s disease has not been easy. Our best results so far are two anti-amyloid monoclonal antibodies, lecanumab (Leqembi) and donanemab (Kizuna). They are both...
Xenon is one of the noble gases. If you remember back to high school chemistry class, the noble gases are all on the right side of the periodic table in group 18: helium (atomic...
People who have not yet read my book, A Tattoo on My Brain: A Neurologist’s Personal Battle against Alzheimer’s Disease, sometimes ask me about the meaning of the title. In 2016, I volunteered for a randomized,...
There is no disagreement that excessive alcohol consumption is bad for the brain. A 2019 review found that heavy alcohol use in humans was universally associated with an increased risk of all-cause dementia and reduced grey...
May there be peace and happiness for all.
Today the Washington Post published my invited column titled “As a doctor, here’s what I have learned from my own Alzheimer’s disease.” I was really pleased with how it turned out. The editing was great,...
Two weeks ago, Lois and I answered questions following a screening of the documentary film A Tattoo On My Brain at the Alzheimer’s Association McGinty Conference in Portland, Oregon. The audience consisted of about 400 people...
Two days ago, Halloween arrived at our house. It has been one of my favorite holidays since my own childhood, but now perhaps even more so, as we share in the excitement and joy...
Recently, I received an invitation to screen the documentary film A Tattoo On My Brain at my high school alma mater, Polytechnic School in Pasadena, California. Poly has it roots in what was initially Throop University,...
So far, three anti-amyloid monoclonal antibodies have been approved in the US by the FDA for treatment of dementia or mild cognitive impairment (MCI) caused by Alzheimer’s disease: aducanumab, lecanemab, and most recently donanemab....
Recent Comments